RxDoctor Payments Data

John Hess, APRN

Psychiatric/Mental Health · Arcadia, FLNPI 1861846115

Payments from drug & device makers

$2,062in general payments, 2019–2025

Across 105 payments — averaging $19.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lundbeck LLC$294
  • Otsuka America Pharmaceutical, Inc.$285
  • AbbVie$199
  • Teva Pharmaceuticals USA, Inc.$171
  • Amgen$159
  • GSK$153
  • plus $801 from 21 others

What the payments were for

  • Food & beverage$2,062100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,062 in reported general payments places this provider in the 70th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida

Medicare billing

Part B allowed, 2024
$189,362
Medicare patients
211
Services billed
2,805

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate24$50,394
RexultiBrexpiprazole32$48,318
PerserisRisperidone14$33,704
Trelegy ElliptaFluticasone/Umeclidin/Vilanter33$25,634
MounjaroTirzepatide13$19,616
MyrbetriqMirabegron24$18,947
Aripiprazole61$6,638
Divalproex Sodium108$3,550
Mirtazapine101$3,008
SymbicortBudesonide/Formoterol Fumarate12$2,868
Quetiapine Fumarate109$1,969
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine23$1,925
Memantine Hcl83$1,906
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine46$1,571
Duloxetine Hcl70$1,465

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt$83$50,39424 claims
Otsuka America Pharmaceutical, Inc.Rexulti$285$48,31832 claims
Indivior Inc.Perseris$27$33,70414 claims
GSKTrelegy Ellipta$153$25,63433 claims
Lilly USA, LLCMounjaro, Olanzapine$72$20,44357 claims
AstraZenecaSymbicort$75$2,86812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Arcadia

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →